Skip to Content

Liletta Approval History

  • FDA approved: Yes (First approved February 26th, 2015)
  • Brand name: Liletta
  • Generic name: levonorgestrel
  • Dosage form: Intrauterine Device
  • Company: Allergan plc
  • Treatment for: Birth Control

Liletta (levonorgestrel) is a hormonal intrauterine device (IUD) for use by women to prevent pregnancy for up to four years.

Development History and FDA Approval Process for Liletta

Aug  6, 2017Approval FDA Approves Medicines360's sNDA for Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Feb 27, 2015Approval FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
Jul 21, 2014Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert IUD

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.